查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1762100

伴随诊断市场分析及预测（至 2034 年）：类型、产品、服务、技术、组件、应用、设备、最终用户、功能

Companion Diagnostics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Device, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 368 Pages | 商品交期: 3-5个工作天内

价格
简介目录

伴随诊断市场预计将从 2024 年的 81 亿美元增加到 2034 年的 154 亿美元，复合年增长率约为 6.6%。伴随诊断市场包括旨在识别可能受益于特定治疗的患者并确保个人化治疗的有效性和安全性的测试。该市场融合了分子诊断、基因组学和生物技术，并受到精准医疗进步的驱动。对个人化治疗和监管支持的日益增长的需求正在推动增长，重点是癌症、感染疾病和遗传疾病。该市场强调诊断公司和製药公司之间的合作，以改善标靶治疗的效果。

行业概况：

全球关税和地缘政治风险正在对伴随诊断市场产生重大影响，尤其是在日本、韩国、中国大陆和台湾地区。日本和韩国的贸易摩擦正推动国内研发投入的增加和战略联盟的建立，以减少对外国技术的依赖。中国大陆强调自力更生，这推动了国内诊断技术的快速发展。台湾在半导体供应链中扮演关键角色，但面临可能影响生产的地缘政治脆弱性。在个人化医疗的推动下，全球伴随诊断市场正经历强劲成长，预计2035年将大幅扩张。然而，中东地区的衝突可能加剧供应链中断，推高能源成本，并影响生产和物流。策略多元化和区域合作对于克服这些挑战至关重要。

市场区隔
类型 体外诊断、体内诊断
产品 检测试剂套件、试剂、设备、软体
服务 咨询、验证、训练、维护
科技 聚合酵素链锁反应（PCR）、次世代定序（NGS）、免疫组织化学（IHC）、原位杂合反应（ISH）、流式细胞技术、质谱分析
成分 生物标誌物、生物资讯学
目的 肿瘤科、神经科、循环系统、感染疾病、自体免疫疾病科
装置 可携式、桌上型、手持式
最终用户 医院、临床实验室、製药公司、研究机构
功能 筛检、监测和预后诊断

市场概况：

伴随诊断市场分为技术、适应症和最终用户三个部分，其中肿瘤学占据主导地位。这种主导地位归因于癌症盛行率的不断上升和个人化医疗的日益普及，而个人化医疗需要准确的诊断才能有效治疗。肿瘤学领域受益于基因组学和分子诊断技术的进步，促进了标靶治疗的开发，以改善患者的治疗效果。新兴的子领域包括神经病学和感染疾病，它们正在推动生物标记识别以及神经退化性疾病疾病和病毒性疾病伴随诊断的发展。这些子领域有可能对市场产生重大影响，因为它们解决了尚未满足的医疗需求并实现了更个人化的治疗方法。此外，次世代定序(NGS) 技术的兴起和人工智慧在诊断中的整合预计将提高伴随诊断的准确性和效率，进一步推动市场成长和多样化。

竞争概况：

伴随诊断市场细分多样，其中肿瘤学应用占据大部分市场份额，这得益于癌症发病率的上升和个人化医疗需求的增加。此外，由于分子诊断技术的进步和人们对精准医疗日益增长的兴趣，感染疾病和心血管应用也占据了相当大的份额。从地区来看，北美凭藉其强大的医疗基础设施和先进诊断技术的高度采用而保持主导地位，而亚太地区则由于医疗投资的增加和患者人数的扩大而经历快速增长。伴随诊断市场的竞争格局由罗氏诊断、雅培实验室和赛默飞世尔科技等主要企业塑造，他们不断创新以增强产品系列併保持市场主导地位。法规结构，尤其是北美和欧洲的监管框架，制定了严格的品质和安全标准，从而影响市场动态。未来，在次世代定序和生物标记发现技术进步的推动下，市场预计将出现强劲成长。儘管监管复杂性和开发成本高等挑战依然存在，但对个人化医疗的日益关注以及製药和诊断公司之间的策略联盟为市场扩张提供了重大机会。

主要趋势和驱动因素：

在个人化医疗和标靶治疗的推动下，伴随诊断市场正经历强劲成长。一个关键趋势是製药公司和诊断设备製造商之间加强合作，共同开发伴随诊断并确保标靶治疗方法。这种协同作用提高了药物的疗效和安全性，促进了市场扩张。监管机构正在简化伴随诊断的核准流程，鼓励创新并加速市场准入。精准医疗的需求正在推动伴随诊断的应用，因为医疗保健提供者正在寻求根据个人基因图谱客製化治疗方案。此外，癌症和慢性病的增加也推动了对先进诊断解决方案的需求，以改善患者的治疗效果。次世代定序和液态切片等技术进步正在透过提供非侵入性和高度准确的诊断选项来改变模式。由于医疗保健投资的增加和对个人化医疗解决方案的日益关注，新兴市场提供了丰厚的机会。利用这些趋势和驱动因素的公司将能够充分利用医疗保健行业不断变化的需求，并占据显着的市场占有率。

限制与挑战：

伴随诊断市场面临许多重大的市场限制与挑战。首先，监管的复杂性构成了巨大的障碍，严格的核准流程不仅延长了审批时间，也推高了成本。这种复杂性往往会阻碍小型公司进入市场。其次，开发和验证伴随诊断的高成本限制了其应用，尤其是在新兴市场。这种经济负担会抑制创新，减缓市场扩张。第三，将伴随诊断整合到现有的临床工作流程中可能非常繁琐，需要对实践进行重大变革，并对医疗专业人员进行额外培训。第四，不同平台之间缺乏标准化，使得伴随诊断的实施更加复杂，并引发了互通性问题。最后，技术的快速进步需要持续的更新和调整，这对于试图跟上不断发展的科学和临床知识的公司来说，可能需要耗费大量的资源。总而言之，这些挑战阻碍了市场的成长轨迹。

目录

第一章伴随诊断市场概述

  • 研究目标
  • 伴随诊断市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章重要考察

第四章伴随诊断市场展望

  • 伴随诊断市场区隔
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章伴随诊断市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章伴随诊断市场规模

  • 伴随诊断市场规模（以价值计算）
  • 伴随诊断市场规模（按数量）

第七章 伴随诊断市场（按类型）

  • 市场概览
  • 体外诊断
  • 体内诊断
  • 其他的

第 8 章伴随诊断市场（按产品）

  • 市场概览
  • 检测试剂套件
  • 试剂
  • 装置
  • 软体
  • 其他的

第九章 伴随诊断市场（按服务）

  • 市场概览
  • 咨询
  • 验证
  • 训练
  • 维护
  • 其他的

第 10 章 伴随诊断市场（按技术）

  • 市场概览
  • 聚合酵素链锁反应（PCR）
  • 次世代定序（NGS）
  • 免疫组织化学（IHC）
  • 原位杂合反应（ISH）
  • 流式细胞技术
  • 质谱法
  • 其他的

第 11 章伴随诊断市场（按组件）

  • 市场概览
  • 生物标誌物
  • 生物资讯学
  • 其他的

第十二章伴随诊断市场（按应用）

  • 市场概览
  • 肿瘤学
  • 神经病学
  • 循环系统
  • 感染疾病
  • 自体免疫疾病
  • 其他的

第十三章 伴随诊断市场（按设备）

  • 市场概览
  • 可携式的
  • 桌面型
  • 手持式
  • 其他的

第 14 章 伴随诊断市场（依最终使用者）

  • 市场概览
  • 医院
  • 临床检测机构
  • 製药公司
  • 研究所
  • 其他的

第十五章 伴随诊断市场（按功能）

  • 市场概览
  • 筛检
  • 监控
  • 预后诊断
  • 其他的

第十六章 伴随诊断市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市场占有率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章 公司简介

  • Myriad Genetics
  • Qiagen
  • Illumina
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Biocartis
  • Guardant Health
  • Foundation Medicine
  • Adaptive Biotechnologies
  • Natera
  • Exact Sciences
  • Invitae
  • NeoGenomics Laboratories
  • Bio-Rad Laboratories
  • Luminex Corporation
  • PerkinElmer
  • Fulgent Genetics
  • Hologic
  • DiaSorin
简介目录
Product Code: GIS10261

Companion Diagnostics Market is anticipated to expand from $8.1 billion in 2024 to $15.4 billion by 2034, growing at a CAGR of approximately 6.6%. Companion Diagnostics Market encompasses tests designed to identify patients likely to benefit from specific therapeutics, ensuring personalized treatment efficacy and safety. This market integrates molecular diagnostics, genomics, and biotechnology, driven by advancements in precision medicine. Increasing demand for tailored therapies and regulatory support propels growth, with a focus on oncology, infectious diseases, and genetic disorders. The market emphasizes collaboration between diagnostic firms and pharmaceutical companies to enhance targeted therapy outcomes.

Industry Overview:

Global tariffs and geopolitical risks are significantly impacting the Companion Diagnostics Market, particularly across Japan, South Korea, China, and Taiwan. In Japan and South Korea, trade tensions are prompting increased investment in local R&D and strategic alliances to mitigate dependency on foreign technologies. China's focus on self-reliance is driving rapid advancements in indigenous diagnostic technologies. Taiwan, while a pivotal player in semiconductor supply chains, faces geopolitical vulnerabilities that could disrupt production. The global market for companion diagnostics is witnessing robust growth, driven by advancements in personalized medicine, with projections indicating substantial expansion by 2035. However, Middle East conflicts could exacerbate supply chain disruptions and elevate energy costs, influencing production and distribution logistics. Strategic diversification and regional collaborations will be crucial to navigating these challenges.

Market Segmentation
TypeIn Vitro Diagnostics, In Vivo Diagnostics
ProductAssay Kits, Reagents, Instruments, Software
ServicesConsultation, Validation, Training, Maintenance
TechnologyPolymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Flow Cytometry, Mass Spectrometry
ComponentBiomarkers, Bioinformatics
ApplicationOncology, Neurology, Cardiology, Infectious Diseases, Autoimmune Diseases
DevicePortable, Benchtop, Handheld
End UserHospitals, Clinical Laboratories, Pharmaceutical Companies, Research Institutes
FunctionalityScreening, Monitoring, Prognosis

Market Overview:

The Companion Diagnostics Market is segmented into technology, indication, and end-user segments, with the oncology segment leading the market. This dominance is attributed to the increasing prevalence of cancer and the growing adoption of personalized medicine, which necessitates precise diagnostics for effective treatment. The oncology segment benefits from technological advancements in genomics and molecular diagnostics, facilitating the development of targeted therapies that improve patient outcomes. Emerging sub-segments include neurology and infectious diseases, driven by advancements in biomarker identification and the development of companion diagnostics for neurodegenerative and viral diseases. These sub-segments hold potential for significant market impact as they address unmet medical needs and enable more tailored therapeutic approaches. Additionally, the rise of next-generation sequencing (NGS) technologies and the integration of artificial intelligence in diagnostics are poised to enhance the accuracy and efficiency of companion diagnostics, further propelling market growth and diversification.

Geographical Overview:

The companion diagnostics market is witnessing diverse growth trends across various regions. North America leads the market, driven by advanced healthcare infrastructure and a strong emphasis on personalized medicine. The region's robust regulatory framework and collaboration between biotech firms and research institutions further bolster its position. Europe follows, characterized by substantial investments in precision medicine and a supportive regulatory environment. The region's focus on innovative healthcare solutions enhances the adoption of companion diagnostics. Additionally, collaborations between pharmaceutical companies and diagnostic firms are prevalent, fostering market growth. In the Asia Pacific, rapid economic growth and increasing healthcare expenditure drive the market. Countries like China and India are investing heavily in healthcare infrastructure, promoting the adoption of companion diagnostics. The region's large patient pool and growing awareness of personalized medicine contribute to its expansion. Latin America and the Middle East & Africa are emerging markets with significant potential. In Latin America, rising investments in healthcare and increasing focus on cancer diagnostics propel market growth. Meanwhile, the Middle East & Africa recognize the importance of personalized medicine, with governments investing in healthcare advancements to support market expansion.

Competition Overview:

The Companion Diagnostics Market is characterized by a diverse segmentation, with oncology applications commanding a significant portion of the market, driven by the increasing prevalence of cancer and the demand for personalized medicine. Infectious diseases and cardiovascular applications also hold substantial shares, owing to advancements in molecular diagnostics and the growing focus on precision healthcare. Geographically, North America maintains a leading position due to robust healthcare infrastructure and high adoption of advanced diagnostic technologies, while the Asia-Pacific region is witnessing rapid growth fueled by rising healthcare investments and expanding patient populations. The competitive landscape of the Companion Diagnostics Market is shaped by key players such as Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific, who are continuously innovating to enhance their product portfolios and maintain market dominance. Regulatory frameworks, particularly in North America and Europe, set stringent standards that drive quality and safety, influencing market dynamics. Looking forward, the market is anticipated to experience robust growth, propelled by technological advancements in next-generation sequencing and biomarker discovery. Challenges such as regulatory complexities and high development costs persist, yet the increasing emphasis on personalized medicine and strategic partnerships between pharmaceutical and diagnostic companies present substantial opportunities for expansion.

Recent Developments:

The Companion Diagnostics Market has witnessed notable developments over the past three months. Roche announced a strategic partnership with Illumina to co-develop and commercialize next-generation sequencing-based companion diagnostics, aiming to enhance precision medicine capabilities. Thermo Fisher Scientific unveiled a new companion diagnostic assay intended to identify patients who could benefit from a novel targeted therapy, thereby broadening their diagnostic portfolio. In a significant merger, Qiagen acquired a smaller biotech firm specializing in companion diagnostics, aiming to strengthen its market position and expand its product offerings. The US FDA granted accelerated approval to a new companion diagnostic test developed by Agilent Technologies, which is designed to identify patients eligible for a specific cancer immunotherapy. Furthermore, a collaborative research initiative between AstraZeneca and a leading academic institution was launched, focusing on the development of innovative companion diagnostics for emerging oncology therapies. These developments underscore the dynamic nature of the Companion Diagnostics Market, emphasizing strategic alliances and regulatory advancements.

Key Companies:

Myriad Genetics, Qiagen, Illumina, Roche Diagnostics, Thermo Fisher Scientific, Agilent Technologies, Biocartis, Guardant Health, Foundation Medicine, Adaptive Biotechnologies, Natera, Exact Sciences, Invitae, Neo Genomics Laboratories, Bio- Rad Laboratories, Luminex Corporation, Perkin Elmer, Fulgent Genetics, Hologic, Dia Sorin

Key Trends and Drivers:

The Companion Diagnostics Market is experiencing robust growth, propelled by advancements in personalized medicine and targeted therapies. A significant trend is the increasing collaboration between pharmaceutical companies and diagnostic manufacturers to co-develop companion diagnostics, ensuring precise treatment regimens. This synergy enhances drug efficacy and safety, fostering market expansion. Regulatory bodies are streamlining approval processes for companion diagnostics, encouraging innovation and accelerating market entry. The demand for precision medicine is driving the adoption of companion diagnostics, as healthcare providers seek to tailor treatments to individual genetic profiles. Moreover, the growing prevalence of cancer and chronic diseases necessitates advanced diagnostic solutions to improve patient outcomes. Technological advancements, such as next-generation sequencing and liquid biopsies, are transforming the landscape, offering non-invasive and highly accurate diagnostic options. Emerging markets present lucrative opportunities, with increasing healthcare investments and a rising focus on personalized healthcare solutions. Companies that leverage these trends and drivers are well-positioned to capture significant market share, capitalizing on the evolving needs of the healthcare industry.

Restraints and Challenges:

The companion diagnostics market is confronted with several significant restraints and challenges. Firstly, regulatory complexities present a formidable barrier, as stringent approval processes extend timelines and inflate costs. This complexity often discourages smaller companies from entering the market. Secondly, the high cost of development and validation of companion diagnostics limits their accessibility, particularly in emerging markets. This financial burden can stifle innovation and slow market expansion. Thirdly, the integration of companion diagnostics into existing clinical workflows can be cumbersome, requiring significant changes in practice and additional training for healthcare professionals. Fourthly, there is a lack of standardization across different platforms, which complicates the deployment of these diagnostics and creates interoperability issues. Lastly, the rapid pace of technological advancements necessitates continuous updates and adaptations, which can be resource-intensive for companies attempting to keep pace with evolving scientific and clinical knowledge. These challenges collectively impede the market's growth trajectory.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Companion Diagnostics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Companion Diagnostics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by End User
  • 2.11 Key Highlights of the Market, by Functionality
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by End User
  • 3.10 Market Attractiveness Analysis, by Functionality
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Companion Diagnostics Market Outlook

  • 4.1 Companion Diagnostics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Companion Diagnostics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Companion Diagnostics Market Size

  • 6.1 Companion Diagnostics Market Size, by Value
  • 6.2 Companion Diagnostics Market Size, by Volume

7: Companion Diagnostics Market, by Type

  • 7.1 Market Overview
  • 7.2 In Vitro Diagnostics
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 In Vivo Diagnostics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Companion Diagnostics Market, by Product

  • 8.1 Market Overview
  • 8.2 Assay Kits
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Reagents
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Companion Diagnostics Market, by Services

  • 9.1 Market Overview
  • 9.2 Consultation
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Validation
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Training
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Maintenance
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Companion Diagnostics Market, by Technology

  • 10.1 Market Overview
  • 10.2 Polymerase Chain Reaction (PCR)
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Next-Generation Sequencing (NGS)
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Immunohistochemistry (IHC)
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 In Situ Hybridization (ISH)
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Flow Cytometry
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Mass Spectrometry
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Companion Diagnostics Market, by Component

  • 11.1 Market Overview
  • 11.2 Biomarkers
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Bioinformatics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: Companion Diagnostics Market, by Application

  • 12.1 Market Overview
  • 12.2 Oncology
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Neurology
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Cardiology
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Infectious Diseases
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Autoimmune Diseases
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Companion Diagnostics Market, by Device

  • 13.1 Market Overview
  • 13.2 Portable
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Benchtop
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Handheld
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Companion Diagnostics Market, by End User

  • 14.1 Market Overview
  • 14.2 Hospitals
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Laboratories
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Pharmaceutical Companies
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Research Institutes
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Companion Diagnostics Market, by Functionality

  • 15.1 Market Overview
  • 15.2 Screening
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Monitoring
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Prognosis
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Companion Diagnostics Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by Device
    • 16.2.9 North America Market Size and Forecast, by End User
    • 16.2.10 North America Market Size and Forecast, by Functionality
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by Device
      • 16.2.9.8 United States Market Size and Forecast, by End User
      • 16.2.9.9 United States Market Size and Forecast, by Functionality
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by Device
      • 16.2.10.8 Canada Market Size and Forecast, by End User
      • 16.2.10.9 Canada Market Size and Forecast, by Functionality
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by Device
    • 16.3.9 Europe Market Size and Forecast, by End User
    • 16.3.10 Europe Market Size and Forecast, by Functionality
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.8 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Functionality
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by Device
      • 16.3.10.8 Germany Market Size and Forecast, by End User
      • 16.3.10.9 Germany Market Size and Forecast, by Functionality
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by Device
      • 16.3.11.8 France Market Size and Forecast, by End User
      • 16.3.11.9 France Market Size and Forecast, by Functionality
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by Device
      • 16.3.12.8 Spain Market Size and Forecast, by End User
      • 16.3.12.9 Spain Market Size and Forecast, by Functionality
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by Device
      • 16.3.13.8 Italy Market Size and Forecast, by End User
      • 16.3.13.9 Italy Market Size and Forecast, by Functionality
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by Device
      • 16.3.14.8 Netherlands Market Size and Forecast, by End User
      • 16.3.14.9 Netherlands Market Size and Forecast, by Functionality
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by Device
      • 16.3.15.8 Sweden Market Size and Forecast, by End User
      • 16.3.15.9 Sweden Market Size and Forecast, by Functionality
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by Device
      • 16.3.16.8 Switzerland Market Size and Forecast, by End User
      • 16.3.16.9 Switzerland Market Size and Forecast, by Functionality
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by Device
      • 16.3.17.8 Denmark Market Size and Forecast, by End User
      • 16.3.17.9 Denmark Market Size and Forecast, by Functionality
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by Device
      • 16.3.18.8 Finland Market Size and Forecast, by End User
      • 16.3.18.9 Finland Market Size and Forecast, by Functionality
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by Device
      • 16.3.19.8 Russia Market Size and Forecast, by End User
      • 16.3.19.9 Russia Market Size and Forecast, by Functionality
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Functionality
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.9 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by Device
      • 16.4.9.8 China Market Size and Forecast, by End User
      • 16.4.9.9 China Market Size and Forecast, by Functionality
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by Device
      • 16.4.10.8 India Market Size and Forecast, by End User
      • 16.4.10.9 India Market Size and Forecast, by Functionality
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by Device
      • 16.4.11.8 Japan Market Size and Forecast, by End User
      • 16.4.11.9 Japan Market Size and Forecast, by Functionality
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by Device
      • 16.4.12.8 South Korea Market Size and Forecast, by End User
      • 16.4.12.9 South Korea Market Size and Forecast, by Functionality
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by Device
      • 16.4.13.8 Australia Market Size and Forecast, by End User
      • 16.4.13.9 Australia Market Size and Forecast, by Functionality
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by Device
      • 16.4.14.8 Singapore Market Size and Forecast, by End User
      • 16.4.14.9 Singapore Market Size and Forecast, by Functionality
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by Device
      • 16.4.15.8 Indonesia Market Size and Forecast, by End User
      • 16.4.15.9 Indonesia Market Size and Forecast, by Functionality
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by Device
      • 16.4.16.8 Taiwan Market Size and Forecast, by End User
      • 16.4.16.9 Taiwan Market Size and Forecast, by Functionality
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by Device
      • 16.4.17.8 Malaysia Market Size and Forecast, by End User
      • 16.4.17.9 Malaysia Market Size and Forecast, by Functionality
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by Device
    • 16.5.9 Latin America Market Size and Forecast, by End User
    • 16.5.10 Latin America Market Size and Forecast, by Functionality
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by Device
      • 16.5.9.8 Brazil Market Size and Forecast, by End User
      • 16.5.9.9 Brazil Market Size and Forecast, by Functionality
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by Device
      • 16.5.10.8 Mexico Market Size and Forecast, by End User
      • 16.5.10.9 Mexico Market Size and Forecast, by Functionality
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by Device
      • 16.5.11.8 Argentina Market Size and Forecast, by End User
      • 16.5.11.9 Argentina Market Size and Forecast, by Functionality
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Functionality
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.9 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Functionality
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Functionality
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by Device
      • 16.6.10.8 UAE Market Size and Forecast, by End User
      • 16.6.10.9 UAE Market Size and Forecast, by Functionality
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by Device
      • 16.6.11.8 South Africa Market Size and Forecast, by End User
      • 16.6.11.9 South Africa Market Size and Forecast, by Functionality
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Functionality
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Myriad Genetics
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Qiagen
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Illumina
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Roche Diagnostics
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Thermo Fisher Scientific
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Agilent Technologies
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Biocartis
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Guardant Health
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Foundation Medicine
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Adaptive Biotechnologies
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Natera
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Exact Sciences
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Invitae
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 NeoGenomics Laboratories
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Bio-Rad Laboratories
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
  • 18.16 Luminex Corporation
    • 18.16.1 Company Overview
    • 18.16.2 Company Snapshot
    • 18.16.3 Business Segments
    • 18.16.4 Business Performance
    • 18.16.5 Product Offerings
    • 18.16.6 Key Developmental Strategies
    • 18.16.7 SWOT Analysis
  • 18.17 PerkinElmer
    • 18.17.1 Company Overview
    • 18.17.2 Company Snapshot
    • 18.17.3 Business Segments
    • 18.17.4 Business Performance
    • 18.17.5 Product Offerings
    • 18.17.6 Key Developmental Strategies
    • 18.17.7 SWOT Analysis
  • 18.18 Fulgent Genetics
    • 18.18.1 Company Overview
    • 18.18.2 Company Snapshot
    • 18.18.3 Business Segments
    • 18.18.4 Business Performance
    • 18.18.5 Product Offerings
    • 18.18.6 Key Developmental Strategies
    • 18.18.7 SWOT Analysis
  • 18.19 Hologic
    • 18.19.1 Company Overview
    • 18.19.2 Company Snapshot
    • 18.19.3 Business Segments
    • 18.19.4 Business Performance
    • 18.19.5 Product Offerings
    • 18.19.6 Key Developmental Strategies
    • 18.19.7 SWOT Analysis
  • 18.20 DiaSorin
    • 18.20.1 Company Overview
    • 18.20.2 Company Snapshot
    • 18.20.3 Business Segments
    • 18.20.4 Business Performance
    • 18.20.5 Product Offerings
    • 18.20.6 Key Developmental Strategies
    • 18.20.7 SWOT Analysis